Creative Touch Permanent Makeup and Aesthetics

Mounjaro can be injected into three areas: the abdomen, the front of the thigh, or the back of the upper arm. ^{[[1], [6]]} Each contains enough subcutaneous fat tissue for proper absorption.

Abdomen (stomach area): Most people find this the easiest site to access. The abdomen typically offers the largest injection area with consistent subcutaneous fat. You’ll need to stay at least 5cm (about 2 inches) away from your belly button, ^[3] but otherwise have plenty of space to work with.

Front of thigh: The second most popular choice for self-injection. You’ll use the front, outer portion of your upper thigh. It’s easy to see what you’re doing, and most people have adequate fat tissue here.

Back of upper arm: This site usually requires someone else to help with the injection, since it’s difficult to reach on your own. The back of the upper arm typically has more subcutaneous fat than the front, making it suitable for injection when you have assistance.

Most of our clients self-inject into either the abdomen or the thigh. The arm tends to work better when a partner or family member is helping.

Most advice about Mounjaro injection sites is based on general principles or personal experience. But there is actual clinical trial data comparing the three sites directly.

Clinical trial NCT04050670 examined the relative bioavailability (AUC and Cmax) and tolerability of a single 5 mg tirzepatide dose injected subcutaneously into abdomen, thigh, and upper arm. The study used a randomized, 3-period crossover design in ~54 participants, with a single 5 mg dose given in each period at different sites (abdomen, thigh, upper arm) separated by washouts. ^[4]

The researchers measured two things: how much medication reached the bloodstream (pharmacokinetics), and what side effects occurred at each site. They compared drug exposure across injection sites using AUC and Cmax. Overall exposure was broadly comparable across sites, although peak levels (Cmax) were modestly lower with thigh and upper-arm injections than with abdomen (details in the Appendix).

But the side effect data told a different story.

Gastrointestinal side effects by injection site

The most striking differences appeared in gastrointestinal symptoms, which are the most common Mounjaro side effects: ^[4]

Nausea affected:

• 37.04% of participants when injecting into the abdomen
• 22.22% when injecting into the upper arm
• 20.75% when injecting into the thigh

That’s a 44% relative reduction in nausea when using the thigh compared to the abdomen.

Vomiting showed an even more dramatic pattern:

• 16.67% with abdominal injections
• 18.52% with upper arm injections
• 7.55% with thigh injections

Thigh injections more than halve the vomiting rate compared to the abdomen.

Indigestion (dyspepsia) followed a similar trend:

• 18.52% with abdomen
• 20.37% with upper arm
• 11.32% with thigh

Other gastrointestinal side effects - constipation, diarrhoea, and flatulence - were reported less often with thigh injections as well. ^[4]

Appetite suppression differences

Here’s an important nuance. Decreased appetite is one of the key mechanisms behind Mounjaro’s weight loss effects. In this trial, the symptom label ‘decreased appetite’ was reported at different rates depending on where the injection was given: ^[4]

• Abdomen: 24.07% reported decreased appetite
• Upper arm: 12.96% reported decreased appetite
• Thigh: 5.66% reported decreased appetite

In the study’s side-effect reporting, ‘decreased appetite’ was recorded approximately four times more often with abdomen injections than with thigh injections. If reducing appetite is your primary goal, this seems significant, but it’s still a side-effect report and not a direct measure of weight-loss results or medication ‘strength.’

In the same dataset, abdomen injections also had higher reported nausea than the other sites, so some people may prefer a site that feels gentler even if it reports ‘decreased appetite’ less often.

Put simply: in this study, ‘decreased appetite’ is being counted as a reported symptom (an adverse-event term), not used as proof that one injection site works better for weight loss.

Other side effects

Headache rates also varied:

• 22.22% with abdomen
• 14.81% with upper arm
• 11.32% with thigh

In this dataset, the thigh had lower reported rates across the majority of adverse events measured in the trial. ^[4]

Here’s the part that’s genuinely puzzling. The trial found broadly comparable systemic exposure across abdomen, thigh and upper arm, meaning the body absorbs a similar overall amount of tirzepatide regardless of site. ^[4]

So why would side effects differ if overall exposure is similar? ^[4]

We don’t have a definitive answer. The researchers didn’t explain this discrepancy, and no follow-up studies have investigated it. But there are a few possible explanations:

Absorption rate vs total absorption: One clue comes from the pharmacokinetics. While overall exposure (AUC) was broadly comparable across sites, peak concentrations (Cmax) were modestly lower with thigh and upper‑arm injections compared with abdomen. That pattern is consistent with a difference in absorption rate rather than the total amount absorbed, potentially influenced by site factors such as local blood flow/perfusion and tissue uptake dynamics. If side effects are partly “peak-driven”, a higher abdominal peak could plausibly trigger more early GI symptoms even when total exposure is similar.

Local Gut Receptor Activation (“The Leakage Theory”): While Mounjaro mimics the GLP-1 hormone naturally produced by your body’s L-cells, it is administered differently. Natural GLP-1 is released directly in the gut. One untested hypothesis is that injecting into abdominal fat - which sits in close proximity to the enteric nervous system (the “second brain” in your gut) - may allow the medication to “leak” or transport locally to gut receptors before it even enters your general circulation. This could trigger nausea more aggressively than an injection in the thigh, which is far removed from the digestive tract.

Local tissue effects: The injection site itself may influence how your body responds locally before the medication enters systemic circulation.

Statistical variation: With a small sample, some differences could still be down to chance.

Study design factors: This was a single-dose study at 5mg. Effects might differ with repeated weekly dosing at higher maintenance doses.

What we can say is this: the pattern observed in our clinic broadly matches what the trial data suggests. Clients who switch to thigh injections often report fewer stomach issues. That’s not proof, but it’s consistent.

This is probably the question you really want answered. And we need to be honest: the trial didn’t directly measure weight loss outcomes. ^[4] It measured pharmacokinetics and side effects, not how much weight people lost.

The higher appetite suppression from abdominal injections could theoretically support greater weight loss. But that’s speculation, not evidence. And even if true, the effect would likely be modest compared to other factors.

Here’s what actually determines long-term success with Mounjaro for weight loss: the lifestyle and dietary changes you make while the medication is helping you eat less. Your injection site choice will be insignificant compared to whether you’re building sustainable habits.

The TOWARDS study, UK primary care data, and other research into life after Mounjaro consistently show that medication adherence and lifestyle modification drive outcomes. Not where you put the needle.

Getting the technique right matters more than which site you choose. And based on the search queries we see, there’s quite a bit of confusion about the specifics.

Where exactly on the thigh?

Use the front, outer portion of your upper thigh only. The upper third, on the anterior-lateral aspect (front and slightly to the outside). ^[5]

Avoid the inner thigh. This isn’t just preference. Clinical guidance for subcutaneous injections explicitly states not to use the inner thigh. ^[5] Three reasons:

1. Higher concentration of nerves, making injections more painful.
2. Proximity to the femoral artery and vein increases the bleeding risk.
3. Variable subcutaneous fat depth raises the chance of accidentally injecting into muscle.

Stick to the front and outer thigh. You’ll have plenty of suitable areas to work with.

How far from your belly button?

At least 5cm, which is about 2 inches. Both measurements appear in different guidance documents, and they’re effectively the same distance.

The area immediately around your navel contains tougher connective tissue that can make injection uncomfortable and potentially affect absorption. Give it a wide berth.

The rest of your abdomen, from about 2.5cm above your pubic bone to just below your lowest rib, and out to the sides, is suitable for injection.

Should you pinch the skin?

This depends on your body composition, and the official prescribing information doesn’t give a universal answer. It states: “Your healthcare provider should tell you if you should pinch the skin before injecting.”

General guidance for subcutaneous injections suggests:

• If you have adequate subcutaneous fat: You may not need to pinch at all with shorter needles.
• If you’re lean: A skin pinch at a 45-degree angle helps ensure the medication goes into fat tissue rather than muscle.
• For arm or thigh injections: These sites typically have thinner subcutaneous layers than the abdomen, so a pinch may be warranted even if you wouldn’t need one for stomach injections.

The Mounjaro pen has a pre-set needle, so you can’t select the length. If you’re uncertain about technique, ask during your next consultation. We always demonstrate proper injection technique with our clients.

What happens if you inject into a muscle?

Mounjaro is designed for subcutaneous injection, meaning into the fat layer beneath your skin. If the needle goes deeper into muscle tissue, several things can happen:

Faster, more variable absorption: Muscle has a richer blood supply than fat tissue, which can speed up how quickly the medication enters your bloodstream. This might intensify side effects.

Increased pain and bruising: Muscle tissue has more nerve endings than subcutaneous fat. You’re more likely to experience discomfort during the injection and bruising afterwards.

Potentially erratic drug levels: The consistent, slow absorption from subcutaneous fat is part of how these medications are designed to work. Intramuscular injection bypasses that.

Prevention is straightforward: use the appropriate technique for your body composition. Lean individuals should use a skin pinch. Avoid pressing too hard. And if you’re concerned, the abdomen typically offers the lowest risk of accidental intramuscular injection because most people have adequate fat there.

The prescribing information for both Mounjaro and Zepbound is clear: “Rotate injection sites with each dose.”

A 2024 meta-analysis examined what happens when people don’t rotate properly. The finding was striking: incorrect injection site rotation was the strongest contributor to lipohypertrophy, with an odds ratio of 8.85. That means people who didn’t rotate were nearly nine times more likely to develop these fatty lumps at injection sites.

Lipohypertrophy might sound like a minor cosmetic issue. It isn’t. These lumps cause erratic, unpredictable drug absorption. For insulin users, this significantly increases the risk of blood sugar swings. For GLP-1 medications like Mounjaro, inconsistent absorption could affect both efficacy and side effects.

How to rotate effectively:

Move at least 1-2cm away from your previous injection site. One practical approach is to divide your injection area into quadrants or zones, use one zone per week, and move systematically (say, clockwise around your abdomen).

Keep a simple record. We recommend clients note their injection site and any side effects for at least the first few months. It helps identify patterns and ensures you’re not unconsciously returning to the same spot.

Here’s what we suggest based on the evidence combined with what we’ve observed supporting clients through their Mounjaro treatment.

If you’re struggling with nausea

Consider switching to thigh injections. The trial data showed roughly half the nausea rate compared to abdominal injections, ^[4] and this matches what we see in practice.

Give it at least two to three weeks to assess whether you notice a difference. Your body needs time to establish a pattern with the new site.

If appetite suppression is your priority

Abdominal injections showed the highest rates of decreased appetite in the trial data. ^[4] If you’re finding that Mounjaro isn’t curbing your appetite as much as you’d hoped, and you’re currently using thigh or arm, trying abdominal injections might help.

But go in with realistic expectations. You’re also accepting a higher likelihood of GI side effects. It’s a trade-off.

When stepping up to a higher dose

This is where our clinical experience adds something that the research doesn’t capture. When you’re moving to a higher dose, whether from 2.5mg to 5mg, or 5mg to 7.5mg, or any other increase, consider using thigh injections for at least the first week.

The logic: your body is adjusting to more medication. Using a site associated with fewer side effects gives you a gentler transition. You can always switch back to your preferred site once you know how your body handles the higher dose.

We’ve seen this approach work well for many clients. It’s not in any official guidance, but it makes practical sense, and consistent administration matters more than always using the same site.

Finding what works for you

Individual responses vary considerably. The trial data show population-level trends, but you’re not a population average. You’re you.

The best approach is systematic experimentation. Track how you feel, then try a different site and compare. Keep notes. Look for patterns.

What works for someone else might not work for you, and vice versa.

We’ve based this guide heavily on NCT04050670 because it’s the only clinical trial directly comparing tirzepatide injection sites. ^[4] But you should know its limitations:

Small sample size: Only 54 participants. That’s enough to detect large differences but might miss subtler patterns.

Single dose only: The trial used 5mg doses. Whether the same patterns hold at maintenance doses of 10mg or 15mg hasn’t been studied.

‘Overtly healthy’ volunteers: Participants had BMIs from 18.5 to 45, but they weren’t specifically people with diabetes or obesity seeking weight loss. The typical Mounjaro user might respond differently.

No replication: No subsequent studies have confirmed or contradicted these findings. In science, a single study is never the final word.

No weight outcomes: The trial measured side effects and pharmacokinetics. It didn’t track whether the injection site affected weight loss over time.

Longer-term clinical outcomes by injection site have not been established by replicated, longer-duration studies; this study was single-dose and focused on PK/tolerability. ^[4]

This is the best evidence we have. It aligns with our observations in practice. But it’s not definitive, and future research may change our understanding.

1. All three sites deliver equivalent medication absorption. Your bloodstream receives the same amount of tirzepatide regardless of where you inject.
2. Trial data suggest thigh injections may produce fewer GI side effects. Nausea and vomiting rates were roughly halved compared to abdominal injections.
3. Abdominal injections showed higher appetite suppression but more side effects. There’s a trade-off to consider based on your priorities.
4. Avoid the inner thigh. Use the front, outer portion only.
5. Stay at least 5cm (2 inches) from your belly button. The tissue there isn’t ideal for injection.
6. Rotate injection sites with each dose. This prevents lipohypertrophy and maintains consistent absorption.
7. Consider thigh injections when stepping up to a higher dose. It may ease the transition.
8. Track your experience. A simple log of injection sites and side effects helps you identify what works for your body.

Your choice of injection site can affect your Mounjaro experience, even though the medication is absorbed similarly regardless of where you inject. The evidence suggests thigh injections offer a gentler side effect profile, while abdominal injections may provide stronger appetite suppression at the cost of more GI discomfort.

There’s no universally “best” site. The right choice depends on your priorities, your body’s response, and what you can sustain comfortably over months or years of treatment.

If you’re starting Mounjaro or struggling with side effects, experimenting with different injection sites is worth trying. Track what happens. Be systematic. And remember that the injection site is just one variable among many that determine your success.

If you’d like support with your weight loss journey, explore our Mounjaro programme or take our food addiction assessment to understand your relationship with food.

Last updated: Dec 2025 Medical review: This article discusses general information about Mounjaro injection sites. It is not a substitute for personalised medical advice. Always follow the guidance provided by your prescribing healthcare professional.